The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study

The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study

Background: Several vaccines have been approved against COVID-19, and 5 have been used in Indonesia. Due to the decrease in antibody levels 3 to 6 months after the second dose of CoronaVac, healthcare workers received the third booster of mRNA vaccine (mRNA-1273) to increase the antibody level. This...

Full description

Bibliographic Details
Main Authors:	Allen Widysanto, Ignatius Bima Prasetya, Tandry Meriyanti, Veli Sungono, Diane Lukito Setiawan, Edy Gunawan, Bayu Adiputra, Jane Olivia Lorens, Theresia Santi, Cindy Meidy Leony Pradhana, Irawan Yusuf, Catherine Gunawan
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Infectious Medicine
Subjects:	Antibodies titer COVID-19 Immune response S-RBD IgG Vaccine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772431X22000491

Similar Items

A Longitudinal Study in Turkiye of Host Ability to Produce Antibodies following a Third Homologous BNT162b2 Vaccination
by: Mustafa Genco Erdem, et al.
Published: (2023-03-01)

Could Prior COVID-19 Affect the Neutralizing Antibody after the Third BNT162b2 Booster Dose: A Longitudinal Study
by: Mustafa Genco Erdem, et al.
Published: (2023-03-01)

Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan
by: Hiraku Sasaki, et al.
Published: (2021-09-01)

A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
by: Hiraku Sasaki, et al.
Published: (2019-09-01)

SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
by: Marc-André Limoges, et al.
Published: (2023-09-01)

Factors associated with the intention to exclusively breastfeed at Siloam Lippo Cikarang Hospital
by: Naomi Dewanto, et al.
Published: (2016-09-01)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
by: Xu Song, et al.
Published: (2023-06-01)

Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test
by: Hyeon Woo Shim, et al.
Published: (2022-08-01)

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
by: Elisabeth Mara, et al.
Published: (2022-12-01)

Durability of S-RBD IgG Antibody Levels after Sinovac Vaccination in Healthcare Workers
by: Jusak Nugraha, et al.
Published: (2022-09-01)

Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients
by: Madanat L, et al.
Published: (2022-06-01)

Management of necrotizing pneumonia with bronchopleural fistula caused by multidrug‐resistant Acinetobacter baumannii
by: Allen Widysanto, et al.
Published: (2020-11-01)

Long time immunogenicity of measles vaccine in the vaccination era: An open question
by: Maria Serena Gallone, et al.
Published: (2017-01-01)

Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia
by: Ignatius Bima Prasetya, et al.
Published: (2021-07-01)

The correlation between serum 25-hydroxy-vitamin D levels and anti-SARS-CoV-2 S-RBD IgG and neutralizing antibody levels among cancer patients receiving COVID-19 vaccines
by: Andhika Rachman, et al.
Published: (2022-12-01)

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chattogram Metropolitan Area, Bangladesh
by: Jahan Ara, et al.
Published: (2022-11-01)

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
by: Franziska Neumann, et al.
Published: (2021-06-01)

Antibody mix-and-read assays based on fluorescence intensity probes
by: Ujwal Patil, et al.
Published: (2021-01-01)

Assessment of protective serum anti-HBsAb levels among previously HBV vaccinated medical residents and its relation to duration and doses of vaccine – single center study
by: Mohamed Hashem, et al.
Published: (2023-11-01)

Immunogram indices in seropositive and seronegative cats for Toxoplasma gondii
by: V. Kusturov, et al.
Published: (2022-07-01)

Vaccine‐Associated Leptospira Antibodies in Client‐Owned Dogs
by: L.E.R. Martin, et al.
Published: (2014-05-01)

A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
by: Nicola Serra, et al.
Published: (2023-06-01)

A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
by: R Manjunath, et al.
Published: (2022-09-01)

Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy
by: Immacolata Polvere, et al.
Published: (2022-05-01)

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
by: Bruna Lo Sasso, et al.
Published: (2021-06-01)

Evaluation of Antibody Response and Side Effects Related to the Number of Inactive and mRNA Vaccine Doses Against COVID-19 in Healthcare Workers
by: Taylan BOZOK, et al.
Published: (2023-03-01)

Comparing Assay Performance of ELISA and Chemiluminescence Immunoassay in Detecting Antibodies to Hepatitis B Surface Antigen
by: Mridula Madiyal, et al.
Published: (2016-11-01)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
by: Maylin Pérez-Bernal, et al.
Published: (2022-12-01)

Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population
by: Mubarak A, et al.
Published: (2022-07-01)

Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis
by: Maria Denaro, et al.
Published: (2023-03-01)

Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination
by: Jodi F. Hedges, et al.
Published: (2021-06-01)

Prevalence of high titered anti-A and anti-B antibodies among O blood group individuals and their associated factors
by: Sujitha Kannan, et al.
Published: (2020-01-01)

Hepatitis B seroprotection in children aged 10-15 years after completion of basic hepatitis B immunizations
by: Novie Homenta Rampengan, et al.
Published: (2017-04-01)

Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V
by: Franklin Claro, et al.
Published: (2022-09-01)

Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar
by: Devendra Bansal, et al.
Published: (2023-02-01)

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
by: Lina Souan, et al.
Published: (2022-04-01)

Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
by: Antonia Anna Lukito, et al.
Published: (2021-07-01)

Factor XIII deficiency in the Saudi population, an underestimated bleeding risk. Review article and an illustrative case report with dental complications
by: Mansour Aljabry
Published: (2023-05-01)

Optical Biosensor for the Detection of Infectious Diseases Using the Copolymer F8T2 with Application to COVID-19
by: Maiara de Jesus Bassi, et al.
Published: (2022-07-01)

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
by: Linhua Tian, et al.
Published: (2021-03-01)